
Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device designed to treat brain diseases using light and sound.

Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device designed to treat brain diseases using light and sound.